Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 2 1Phase 1/2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 12Triple Negative Breast Neoplasms 2Prostatic Neoplasms 2Neoplasms 2Neoplasm Metastasis 2Endometrial Neoplasms 2Uterine Cervical Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumors Harboring a BRAF V600 Mutation 1Ovarian Neoplasms 1Neoplasms by Site 1Melanoma 1Hereditary Sensory and Autonomic Neuropathies 1Head and Neck Neoplasms 1HER2 Negative Breast Cancer Not Immediately Operated 1Glioma 1Fallopian Tube Neoplasms 1ER+ HER2- Advanced Breast Cancer 1Diffuse Intrinsic Pontine Glioma 1Colorectal Neoplasms 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1Breast Diseases 1Anatomic Stage II Breast Cancer AJCC v8 1

Interventions

Temozolomide 3Bevacizumab 3Re-Irradiation 2Nivolumab 2Irinotecan 2Cetuximab 2ribociclib 1pembrolizumab 1lutetium Lu 177 dotatate 1dostarlimab 1dipinacoline glutamate 1dinutuximab 1cemiplimab 1abemaciclib 1Vorinostat 1Vincristine 1Specimen Handling 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Radiotherapy 1Mebendazole 1Maintenance 1Granulocyte-Macrophage Colony-Stimulating Factor 1Fluid Therapy 1Eflornithine 1Congresses as Topic 1Carboplatin 1CBLC137 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Diffuse Intrinsic Pontine Glioma × ribociclib × Clear all
NCT02607124 2020-11-05

A Phase I/II Study of Ribociclib,a CDK4/6 Inhibitor, Following Radiation Therapy

Children's Hospital Medical Center, Cincinnati

Phase 1/2 Terminated
11 enrolled 10 charts
CNS

Diffuse Intrinsic Pontine Glioma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡